Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362474642> ?p ?o ?g. }
- W4362474642 abstract "Abstract Introduction Critical care pharmacists improve the quality and efficiency of medication therapy whilst reducing treatment costs where they are available. UK critical care pharmacist deployment was described in 2015, highlighting a deficit in numbers, experience level, and critical care access to pharmacy services over the 7-day week. Since then, national workforce standards have been emphasised, quality indicators published, and service commissioning documents produced, reinforced by care quality assessments. Whether these initiatives have resulted in further development of the UK critical care pharmacy workforce is unknown. This evaluation provides a 2020 status update. Methods The 2015 electronic data entry tool was updated and circulated for completion by UK critical care pharmacists. The tool captured workforce data disposition as it was just prior to the COVID-19 pandemic, at critical care unit level. Main findings Data were received for 334 critical care units from 203 organisations (96% of UK critical care units). Overall, 98.2% of UK critical care units had specific clinical pharmacist time dedicated to the unit. The median weekday pharmacist input to each level 3 equivalent bed was 0.066 (0.043–0.088) whole time equivalents, a significant increase from the median position in 2015 (+ 0.021, p < 0.0001). Despite this progress, pharmacist availability remains below national minimum standards (0.1/level 3 equivalent bed). Most units (71.9%) had access to prescribing pharmacists. Geographical variation in pharmacist staffing levels were evident, and weekend services remain extremely limited. Conclusions Availability of clinical pharmacists in UK adult critical care units is improving. However, national standards are not routinely met despite widely publicised quality indicators, commissioning specifications, and assessments. Additional measures are needed to address persistent deficits and realise gains in organisational and patient-level outcomes. These measures must include promotion of cross-professional collaborative working, adjusted funding models, and a nationally recognised training pathway for critical care pharmacists." @default.
- W4362474642 created "2023-04-05" @default.
- W4362474642 creator A5003645610 @default.
- W4362474642 creator A5011800254 @default.
- W4362474642 creator A5024816143 @default.
- W4362474642 creator A5031234801 @default.
- W4362474642 creator A5035107612 @default.
- W4362474642 creator A5037402847 @default.
- W4362474642 creator A5044296320 @default.
- W4362474642 creator A5048547708 @default.
- W4362474642 creator A5053633594 @default.
- W4362474642 creator A5054503581 @default.
- W4362474642 creator A5059760490 @default.
- W4362474642 creator A5066220489 @default.
- W4362474642 creator A5083249545 @default.
- W4362474642 date "2023-03-31" @default.
- W4362474642 modified "2023-09-30" @default.
- W4362474642 title "Critical care pharmacy workforce: a 2020 re-evaluation of the UK deployment and characteristics" @default.
- W4362474642 cites W2051162794 @default.
- W4362474642 cites W2062760514 @default.
- W4362474642 cites W2069783605 @default.
- W4362474642 cites W2153206021 @default.
- W4362474642 cites W2174238491 @default.
- W4362474642 cites W2176991574 @default.
- W4362474642 cites W2260060769 @default.
- W4362474642 cites W2598726010 @default.
- W4362474642 cites W2725158288 @default.
- W4362474642 cites W2741769652 @default.
- W4362474642 cites W2749694042 @default.
- W4362474642 cites W2761525331 @default.
- W4362474642 cites W2782046351 @default.
- W4362474642 cites W2790135818 @default.
- W4362474642 cites W2853366351 @default.
- W4362474642 cites W2905159420 @default.
- W4362474642 cites W2946209372 @default.
- W4362474642 cites W2959672282 @default.
- W4362474642 cites W2962718894 @default.
- W4362474642 cites W3080795376 @default.
- W4362474642 cites W3091118564 @default.
- W4362474642 cites W3121189788 @default.
- W4362474642 cites W3137561014 @default.
- W4362474642 cites W3157081336 @default.
- W4362474642 cites W3159687851 @default.
- W4362474642 cites W4253475883 @default.
- W4362474642 cites W4378759926 @default.
- W4362474642 doi "https://doi.org/10.1186/s12960-023-00810-y" @default.
- W4362474642 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37004069" @default.
- W4362474642 hasPublicationYear "2023" @default.
- W4362474642 type Work @default.
- W4362474642 citedByCount "2" @default.
- W4362474642 countsByYear W43624746422023 @default.
- W4362474642 crossrefType "journal-article" @default.
- W4362474642 hasAuthorship W4362474642A5003645610 @default.
- W4362474642 hasAuthorship W4362474642A5011800254 @default.
- W4362474642 hasAuthorship W4362474642A5024816143 @default.
- W4362474642 hasAuthorship W4362474642A5031234801 @default.
- W4362474642 hasAuthorship W4362474642A5035107612 @default.
- W4362474642 hasAuthorship W4362474642A5037402847 @default.
- W4362474642 hasAuthorship W4362474642A5044296320 @default.
- W4362474642 hasAuthorship W4362474642A5048547708 @default.
- W4362474642 hasAuthorship W4362474642A5053633594 @default.
- W4362474642 hasAuthorship W4362474642A5054503581 @default.
- W4362474642 hasAuthorship W4362474642A5059760490 @default.
- W4362474642 hasAuthorship W4362474642A5066220489 @default.
- W4362474642 hasAuthorship W4362474642A5083249545 @default.
- W4362474642 hasBestOaLocation W43624746421 @default.
- W4362474642 hasConcept C10446079 @default.
- W4362474642 hasConcept C104863432 @default.
- W4362474642 hasConcept C138816342 @default.
- W4362474642 hasConcept C155663085 @default.
- W4362474642 hasConcept C159110408 @default.
- W4362474642 hasConcept C160735492 @default.
- W4362474642 hasConcept C162324750 @default.
- W4362474642 hasConcept C2777512617 @default.
- W4362474642 hasConcept C2778139618 @default.
- W4362474642 hasConcept C2779457091 @default.
- W4362474642 hasConcept C2779891985 @default.
- W4362474642 hasConcept C2780877353 @default.
- W4362474642 hasConcept C2781050511 @default.
- W4362474642 hasConcept C50522688 @default.
- W4362474642 hasConcept C512399662 @default.
- W4362474642 hasConcept C71924100 @default.
- W4362474642 hasConceptScore W4362474642C10446079 @default.
- W4362474642 hasConceptScore W4362474642C104863432 @default.
- W4362474642 hasConceptScore W4362474642C138816342 @default.
- W4362474642 hasConceptScore W4362474642C155663085 @default.
- W4362474642 hasConceptScore W4362474642C159110408 @default.
- W4362474642 hasConceptScore W4362474642C160735492 @default.
- W4362474642 hasConceptScore W4362474642C162324750 @default.
- W4362474642 hasConceptScore W4362474642C2777512617 @default.
- W4362474642 hasConceptScore W4362474642C2778139618 @default.
- W4362474642 hasConceptScore W4362474642C2779457091 @default.
- W4362474642 hasConceptScore W4362474642C2779891985 @default.
- W4362474642 hasConceptScore W4362474642C2780877353 @default.
- W4362474642 hasConceptScore W4362474642C2781050511 @default.
- W4362474642 hasConceptScore W4362474642C50522688 @default.
- W4362474642 hasConceptScore W4362474642C512399662 @default.
- W4362474642 hasConceptScore W4362474642C71924100 @default.
- W4362474642 hasIssue "1" @default.
- W4362474642 hasLocation W43624746421 @default.